ICS stunt growth, slightly

A LARGE meta-analysis shows that inhaled corticosteroids (ICS) stunt growth in children but specialists want parents to be reassured the outcome is “almost imperceptible”.

The study, funded by Asthma UK, found that in the worst case scenario children on ICS were 1.2cm shorter by adulthood than those taking placebo.

There were also “consistent findings” suggesting a dose-response relationship, where lower doses had less of an impact on height than higher doses.

“The results… are a great example of data that may be described as statistically significant, but are in fact